Regenxbio Inc. (RGNX)
Market Closed
17 Jul, 20:00
$
9. 89
-1.31
-11.6964%
$
635.36M Market Cap
- P/E Ratio
- Div Yield
7.52M Volume
-4.53 Eps
$ 11.2
Previous Close 
Want to track RGNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regenxbio Inc. (RGNX) Statistics
Valuation metrics
Market Cap 635.36M
Enterprise value 567.13M
Trailing P/E (ttm) -1.77
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 5.82
Price/Book (mrq) 24.6
Enterprise Value/Revenue 6.46
Enterprise Value/EBITDA -2.47
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 7.07M
Average volume (90 days) 1.75M
Price summary
52-Week low 5.46
52-Week high 16.19
Beta -
50-Day moving average 7.73
200-Day moving average 9.75
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.3%
Operating margin -2.92%
Operational effectiveness
Return on assets -0.85%
Return on equity -2.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.68
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.87
Total debt (mrq) -
Total Debt/Equity (mrq) 3.37
Current ratio (mrq) 2.62%
Book value per share (mrq) 0.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
